Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial.
暂无分享,去创建一个
H. Bartelink | L. Boersma | E. van Werkhoven | J. Maduro | P. Brouwers | A. Fourquet | C. Lemanski | J. V. van Loon | N. Russell | P. Poortmans | A. H. Westenberg | D. Schinagl | L. Scheijmans
[1] J. Yarnold,et al. Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? The Experience of the Standardisation of Breast Radiotherapy (START) Trials in Early Breast Cancer. , 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).
[2] T. Yu. 1565 Objective measurement of cosmetic outcomes of breast conserving therapy using BCCT.core , 2015 .
[3] Sung-Won Kim,et al. Objective Measurement of Cosmetic Outcomes of Breast Conserving Therapy Using BCCT.core , 2015, Cancer research and treatment : official journal of Korean Cancer Association.
[4] Jane M. Young,et al. Comparison of ECOG/WHO performance status and ASA score as a measure of functional status. , 2015, Journal of pain and symptom management.
[5] C. Terwee,et al. Cosmetic Outcome Assessment following Breast-Conserving Therapy: A Comparison between BCCT.core Software and Panel Evaluation , 2014, International journal of breast cancer.
[6] C. Coles,et al. Patient reported outcome measures (PROMs) following forward planned field-in field IMRT: results from the Cambridge Breast IMRT trial. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] C. Coles,et al. Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] G. Calais,et al. Depression is associated with some patient‐perceived cosmetic changes, but not with radiotherapy‐induced late toxicity, in long‐term breast cancer survivors , 2013, Psycho-oncology.
[9] J. Yarnold,et al. OC-0135 CAN PATIENT REPORTED OUTCOME MEASURES REPLACE CLINICAL ASSESSMENTS IN BREAST RADIOTHERAPY TRIALS? , 2012 .
[10] G. Lázár,et al. Cosmetic Outcome 1–5 Years After Breast Conservative Surgery, Irradiation and Systemic Therapy , 2012, Pathology & Oncology Research.
[11] Y. Chin,et al. Radiotherapy breast boost with reduced whole-breast dose is associated with improved cosmesis: the results of a comprehensive assessment from the St. George and Wollongong randomized breast boost trial. , 2012, International journal of radiation oncology, biology, physics.
[12] Jaime S. Cardoso,et al. Turning subjective into objective: the BCCT.core software for evaluation of cosmetic results in breast cancer conservative treatment. , 2007, Breast.
[13] M. Gnant,et al. The use of a breast symmetry index for objective evaluation of breast cosmesis. , 2007, Breast.
[14] Jaime S. Cardoso,et al. Towards an intelligent medical system for the aesthetic evaluation of breast cancer conservative treatment , 2007, Artif. Intell. Medicine.
[15] H. Bartelink,et al. The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. , 1999, International journal of radiation oncology, biology, physics.
[16] Tomas Kron,et al. A comparison of methods of cosmetic assessment in breast conservation treatment , 1996 .
[17] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.
[18] J R Yarnold,et al. Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 1. Comparison of patients' ratings, observers' ratings, and objective assessments. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[19] S Hellman,et al. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. , 1979, International journal of radiation oncology, biology, physics.
[20] Jacob Cohen,et al. Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit. , 1968 .
[21] E. van Limbergen,et al. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. , 2015, The Lancet. Oncology.
[22] M. Golatta,et al. Aesthetics in Breast Conserving Therapy: Do Objectively Measured Results Match Patients’ Evaluations? , 2010, Annals of Surgical Oncology.